Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PHI | WK |
|---|---|---|
| Price | $18.15 | $71.88 |
| Change today | ▲ 3.36% | ▲ 0.91% |
| Market cap | $3.92B | $3.91B |
| Return, 3 months | +3.8% | +35.7% |
| Return, year to date | -9.8% | -16.7% |
| Return, 1 year | +3.9% | -19.2% |
| P/E (TTM) | 8.9 | 85.6 |
| P/B | 1.8 | -40.3 |
| P/E percentile vs own 5y | 21st | – |
| Dividend yield | 8.48% | – |
| Revenue growth (YoY, latest qtr) | +0.7% | +19.7% |
| Net profit growth (YoY) | -6.7% | +52.5% |
| Gross margin | 85.8% | 78.5% |
| Operating margin | 23.9% | -4.8% |
| Net margin | 12.5% | -3.0% |
| Return on equity | 21.5% | – |
| Analyst target vs. price | – | +27.4% |
| Analyst buy share | – | 100% |
| RSI (14) | 55 | 53 |
| 30-day volatility | 27.7% | 42.3% |
| Max drawdown, 1 year | -26.5% | -52.5% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
